1384840-68-9Relevant academic research and scientific papers
Binding model for the interaction of anticancer arylsulfonamides with the p300 transcription cofactor
Shi, Qi,Snyder, James P.,Yin, Shaoman,Kaluz, Stefan,Devi, Narra Sarojini,Van Meir, Erwin G.,Goodman, Mark M.,Ni, Nanting,Wang, Danzhu,Damera, Krishna,Chen, Weixuan,Burroughs, Sarah,Mooring, Suazette Reid,Wang, Binghe,Mun, Jiyoung
supporting information, p. 620 - 625,6 (2020/08/31)
Hypoxia inducible factors (HIFs) are transcription factors that activate expression of multiple gene products and promote tumor adaptation to a hypoxic environment. To become transcriptionally active, HIFs associate with cofactors p300 or CBP. Previously, we found that arylsulfonamides can antagonize HIF transcription in a bioassay, block the p300/HIF-1α interaction, and exert potent anticancer activity in several animal models. In the present work, KCN1-bead affinity pull down, 14C-labeled KCN1 binding, and KCN1-surface plasmon resonance measurements provide initial support for a mechanism in which KCN1 can bind to the CH1 domain of p300 and likely prevent the p300/HIF-1α assembly. Using a previously reported NMR structure of the p300/HIF-1α complex, we have identified potential binding sites in the p300-CH1 domain. A two-site binding model coupled with IC50 values has allowed establishment of a modest ROC-based enrichment and creation of a guide for future analogue synthesis.
